Dr Katherine Bowen promoted to Vice President of Regulatory Affairs
Boyds is delighted to announce the appointment of Dr Katherine Bowen to Vice President of Regulatory Affairs. Katherine joined Boyds in 2022 as Senior Director of Regulatory Affairs. Since then, she has led client projects, providing strategic and operational regulatory advice to facilitate regulatory input, incentives, and early market access. With over 16 years’ experience […]
Prof Alan Boyd awarded Fellowship of the British Pharmacological Society
Professor Alan Boyd, CEO and President of Boyds, has been awarded Fellowship of the British Pharmacological Society (BPS). The prestigious award recognises Alan’s standout contribution to pharmacology.
Boyds appoints regulatory affairs professional
Boyds is delighted to announce the appointment of Matt O’Connor who joins the company as Senior Manager, Regulatory Affairs. Matt joins Boyds following more than five years at DLRC, where he gained broad experience across the regulatory lifecycle, supporting regulatory procedures in varied therapeutic areas. He is also a Matt is also a member of […]
Trio of shortlistings for Boyds in TOPRA Awards 2024
The Boyds team made the shortlist for three categories in the TOPRA Awards for Regulatory Excellence. The TOPRA Awards for Regulatory Excellence are the annual international awards for celebrating achievement and best practice in regulatory affairs. Eamonn McGowran, Associate Director of Regulatory Affairs at Boyds, was named a finalist in the Contribution category which honours […]
Regulatory Submissions
Welcome to Conversations in Drug Development, brought to you by the team at Boyds. This podcast is for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development.
Boyds announces four promotions
Boyds is pleased to announce the following promotions across the company.
Navigating the challenges of developing delivery devices for cell and gene therapy products in Europe
An article authored by Dr Patrick Ginty, Senior Director of Regulatory Affairs at Boyds, and Eamonn McGowran, Associate Director of Regulatory Affairs, has been published in Cell & Gene Therapy Insights’ August 2024 ‘Spotlight On’ innovation in cellular immunotherapy.
Medical student guest blog: my work placement at Boyds
Boyds recently welcomed fifth year medical student Sam Mayhew to the company for work experience, where he undertook a research project. In this guest blog, Sam describes his background, his placement at Boyds, and what he gained from the experience. I am a fifth-year medical student studying at the University of Birmingham. During my time […]
Dr Harriet Gray Stephens completes Pharmaceutical Medicine Specialty Training
An article authored by Dr Harriet Gray Stephens MFPM, medical director at Boyds, has been published on the Clinical Leader website.
Dr Harriet Gray Stephens discusses the pros and cons of synthetic control arms in clinical trials
An article authored by Dr Harriet Gray Stephens MFPM, medical director at Boyds, has been published on the Clinical Leader website.
